Apr. 18, 2025 — A team led by researchers say public ignorance and apathy towards bird flu (highly pathogenic avian influenza, or HPAI) could pose a serious obstacle to containing the virus and ...

Arrow Therapeutics focused exclusively on novel antiviral drug discovery and development, including several different approaches towards Hepatitis C and Respiratory Syncytial Virus (RSV).

Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Action News anchor Vanessa Vasconcelos sat down with Emergency Physician Doctor Rais Vohra to talk about viruses like the Flu ...

The virus causes an infection in the lungs and airways, with most people likely to experience mild to severe cold-like symptoms – 9266 cases of RSV have already been reported in Queensland this ...

The US Department of Health and Human Services (HHS) has launched a $500m initiative to accelerate the development of ...

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant ...

Following after are RSV vaccines from Johnson & Johnson as well as Moderna, in what is shaping gup to be a fiercely contested market. AZ, Sanofi antibody aces phase 3 trial ...

The monoclonal antibody nirsevimab, designed to mimic natural antibodies, significantly reduces severe RSV-related ...